Laser treatment of wet AMD can effectively eliminate leaky blood vessels that cause vision loss, helping slow its progress but often not leading to improved vision. In wet AMD, the

Neovascular age related macular degeneration (wet AMD) is one of the primary causes of blindness in Germany, in which central vision becomes impaired due to choroidal neovascularization. Ranibizumab is an

Age-related macular degeneration, more commonly known by its acronym ARMD, is a disease which causes blurring to your central vision due to damage to the retina – a light-sensing tissue

Dry macular degeneration causes gradual vision loss. It may result in yellow deposits called drusen to form beneath the retina, with symptoms including impaired face or color recognition, blurry or

Researchers in Melbourne have devised an early form of macular degeneration treatment using laser light: injecting an antibody that adheres to new blood vessels and then shining an invisible laser

There are a range of treatments available to slow the progression of dry age-related macular degeneration, including nutritional supplements, injections and cell-based interventions. Wet AMD occurs when abnormal blood vessels

Current treatments for dry age-related macular degeneration lack any efficacy; the disease causes painless loss of central vision beginning with blurry or discolored spots that fade with bright lighting conditions.

Macular degeneration is the gradual loss of central vision that makes it hard to identify faces, drive safely or read, or read without reading glasses. Additionally, this condition can cause